Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Raymond James

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022

Analysts Think Intuitive Surgical Painted 'Cautious Picture' For Procedure Guidance

Analysts Think Intuitive Surgical Painted 'Cautious Picture' For Procedure Guidance

Wells Fargo writes that despite the beat in Q1, Intuitive Surgical Inc (NASDAQ:ISRG) sounded cautious on U.S. capital placements, given rising interest rates and inflationary pressure at hospitals. "We think this commentary was partly driven by the need to recalibrate Street models for fewer trade-ins as the number of legacy Si systems declines. Overall,…

These Netflix Analysts Aren't Confident Of A Turnaround Within The Next 18 Months

These Netflix Analysts Aren't Confident Of A Turnaround Within The Next 18 Months

Netflix Inc (NASDAQ: NFLX) reported a revenue miss and a loss of net paid adds for the first quarter.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Analysts Bump Up CSX Price Target Post Q1 Results

CSX Corp's (NASDAQ:CSX) price target has been raised by two analysts post Q1 results. Raymond James analyst Patrick Tyler Brown raised CSX’s price target to $40 (an upside of 10%) from $39 while maintaining the Outperform rating on the shares. The analyst states that CSX continues to execute its PSR initiatives to drive operational improvement,…

What Does Raymond James, Wells Fargo Have To Say On Abbott's Q1 Earnings

Raymond James thinks Abbott Laboratories' (NYSE: ABT) 1Q results were solid and demonstrated the durable nature of ABT's portfolio, as three out of four business segments grew over 10% organically, with Nutrition growing 8%

Johnson & Johnson Whale Trades For April 20

A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 11 strange trades.

Abbott Clocks Q1 COVID-19 Test Sales Of $3.3B, Reaffirms FY22 EPS Outlook

Abbott Laboratories (NYSE:ABT) has reported Q1 FY22 adjusted EPS of $1.73, up 31.1% Y/Y, better than the consensus of $1.47 and the management guidance of $1.50. Q1 sales of $11.9 billion increased 13.8% on a reported basis and 17.5% on an organic basis, beating the consensus of $11.02 billion. Worldwide sales, excluding…

inkl

Read news from The Economist, FT, and more,
with one subscription

Raymond James Lists Key Takeaways From Qualtrics' Proxy Filing

Raymond James Lists Key Takeaways From Qualtrics' Proxy Filing

Qualtrics International Inc's (NASDAQ:XM) April 15 proxy filing also disclosed new ACV and retention metrics pertinent to investors, Raymond James observed. Qualtrics added $365.1 million in new software ACV billings in 2021, effectively aligning with the target performance level of $365.0 million. Total research services billing of $160.1 million also were effectively in-line…

Raymond James Says Coupa Beat Oracle and SAP In Software Market Share Gains

Raymond James Says Coupa Beat Oracle and SAP In Software Market Share Gains

Raymond James observed Gartner's report that saw Coupa Software Inc (NASDAQ: COUP) gain ~135 points of software market share in procurement, with a growth of 35%, more than double the industry average at ~16%.

Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2022

Raymond James Thinks Med Tech Investors are Somewhat 'Paralyzed' Ahead Of Q1 Earnings

Raymond James Thinks Med Tech Investors are Somewhat 'Paralyzed' Ahead Of Q1 Earnings

Raymond James has outlined its expectations for next week when Johnson & Johnson (NYSE:JNJ), Abbott Laboratories (NYSE:ABT), and Intuitive Surgical Inc (NASDAQ:ISRG) will report Q1 FY22 earnings. Analysts believe that the Med Tech investors have become somewhat 'paralyzed' given the macro/factor-driven concerns. On the macro, investor attention seems to be focused less on revenue growth and more…

Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022

Raymond James Maintains Strong Buy Rating for Copa Holdings, Lowers Price Target To $110

Raymond James Maintains Strong Buy Rating for Copa Holdings, Lowers Price Target To $110

Raymond James has decided to maintain its Strong Buy rating of Copa Holdings (NYSE:CPA) and lower its price target from $115.00 to $110.00. Shares of Copa Holdings are trading up 2.68% over the last 24 hours, at $78.04 per share.

Raymond James Cuts Copa's Price Target By 4%

Raymond James Cuts Copa's Price Target By 4%

Raymond James analyst Savanthi Syth lowered the price target on Copa Holdings (NYSE:CPA) to $110 (an upside of 42%) from $115 while maintaining the Strong Buy rating on the shares. Copa is a Panamanian holding company consisting of Copa Airlines and Copa Colombia. The analyst revised the forecast to reflect higher fuel price forecasts, particularly…

Get all your
news in one place.

100's of premium titles.
One news app.

This Is What Whales Are Betting On Marathon Petroleum

A whale with a lot of money to spend has taken a noticeably bearish stance on Marathon Petroleum. Looking at options history for Marathon Petroleum (NYSE:MPC) we detected 15 strange trades.

Fastly Shares Pop On Takeover Speculation

Fastly Inc (NYSE:FSLY) is surging on a speculative rumor that it could be a takeover target by Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL). A company like Google could acquire Fastly to improve its content delivery network, the Deal.com reported. Fastly operated a content delivery network to help entities provide faster and more reliable online content. Fastly reported…

Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022

10 Biggest Price Target Changes For Wednesday

Raymond James reduced the price target on Intercontinental Exchange, Inc. (NYSE: ICE) from $161 to $157. Intercontinental Exchange shares rose 0.2% to $130.79 in pre-market trading.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga's Top Ratings Upgrades, Downgrades For April 5, 2022

Raymond James Remains Bullish On This Vehicle Manufacturer - Read Why

Raymond James analyst Joseph Altobello raised the price target on BRP Inc (NASDAQ: DOOO) to C$146 from C$137 and kept a Strong Buy rating on the shares.

Analysts Slash Price Target On This Restaurant Company Post Q3 Results

Credit Suisse analyst Lauren Silberman lowered the price target on Darden Restaurants Inc (NYSE:DRI) from $180 to $175 and maintained Outperform rating on the shares. The revised price target implies a 34% upside. While the analyst acknowledged the concerns about the discretionary nature of casual dining, she believes Darden is well-positioned to wade through near-term…

Okta Gets a Downgrade Post Data Breach Incident

Raymond James analyst Adam Tindle downgraded Okta Inc (NASDAQ:OKTA) to Market Perform from Strong Buy and removed his previous $260 price target. His prior thesis was that Okta could become a "platform cloud," similar to Salesforce.com Inc (NYSE:CRM). However, his channel conversations have suggested a continually disconnected CIAM go-to-market strategy. Meanwhile, although partners were willing to trust…

Integral Ad Science Shares Pop As Raymond James Upgrades To Strong Buy

Raymond James analyst Andrew Marok upgraded Integral Ad Science Holding Corp (NASDAQ:IAS) to Strong Buy from Outperform with a price target of $27, up from $26. The price target implies an upside of 69%. Marok had a strong conviction level in Integral Ad Science's long-term fundamental prospects combined with the stock's recent selloff, which he…

Why Nokia Shares Are Rising Today

Raymond James upgraded Nokia Oyj (NYSE: NOK), citing "improving competitive position" and rebuilding confidence in management.

Analysts Continue To See Sharp Upside In Bumble Post Q4

Analysts continue to see sharp upside in Bumble Inc (NASDAQ:BMBL) despite cutting their price targets post Q4 results. BMO Capital analyst Daniel Salmon upgraded to Outperform from Market Perform with an unchanged price target of $48 (103% upside). Online dating is poised to outperform the internet sector. Cowen analyst John Blackledge raised the price target to $38…

1 … 8 9 10 11

People

Justin Patterson

Barton Crockett

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Delta Air Lines

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

375,094 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play